Deodhar A, et al. Secukinumab 150 mg Significantly Improved Signs and Symptoms of Non-radiographic Axial Spondyloarthritis: Results from a Phase 3 Double-blind, Randomized, Placebo-controlled Study. Presented at ACR/ARP Annual Meeting - American College of Rheumatology; 8-13 November, 2019; Atlanta, Georgia, USA. Abstract number: L21.
Strand V and Singh JA. Evaluation and Management of the Patient with Suspected Inflammatory Spine Disease. Mayo Clin Proc 2017; 92:555–564.
Mease PJ, et al. Characterization of patients with ankylosing spondylitis and nonradiographic axial spondyloarthritis in the US-based Corrona Registry. Arthritis Care Res (Hoboken). 2018;70(11):1661-1670.
Landewe R, et al. Clinical Tools to Assess and Monitor Spondyloarthritis. Curr Rheumatol Rep. 2015; 17(7): 47.